trending Market Intelligence /marketintelligence/en/news-insights/trending/fcFc1RHb7-04KTrvOPPi8Q2 content esgSubNav
Log in to other products

 /


Looking for more?

Contact Us
In This List

Biogen Idec ends collaborative agreement with Proteostasis Therapeutics

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Video

COVID-19 Impact & Recovery: Healthcare Outlook for H2 2021

Blog

Corporate Credit Risk Trends in Developing Markets: A Loss Given Default (LGD) Perspective

Blog

Corporate Credit Risk Trends in Developing Markets: A Probability of Default Perspective


Biogen Idec ends collaborative agreement with Proteostasis Therapeutics

Proteostasis Therapeutics Inc. is no longer in a partnership to develop treatments for Alzheimer's and Parkinson's diseases with Biogen Idec New Ventures Inc.

Biogen Idec terminated the partnership after Proteostasis failed to produce a lead compound that could be advanced as a drug candidate.